{"id":"https://openalex.org/W2006508449","doi":"https://doi.org/10.1038/ncponc1298","title":"Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer","display_name":"Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer","alternate_titles":[],"publication_year":2008,"publication_date":"2008-12-23","ids":{"openalex":"https://openalex.org/W2006508449","doi":"https://doi.org/10.1038/ncponc1298","mag":"2006508449","pmid":"https://pubmed.ncbi.nlm.nih.gov/19107109"},"language":"en","primary_location":{"id":"doi:10.1038/ncponc1298","doi":"https://doi.org/10.1038/ncponc1298","is_oa":false,"landing_page_url":"https://doi.org/10.1038/ncponc1298","pdf_url":null,"source":{"id":"https://openalex.org/S4210176377","display_name":"Nature Clinical Practice Oncology","issn_l":"1743-4254","issn":["1743-4254","1743-4262"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Clinical Practice Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2006508449"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081344507","display_name":"Gabriella Mariani","orcid":"https://orcid.org/0000-0001-7733-3143","observed_orcids":["https://orcid.org/0000-0001-7733-3143"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gabriella Mariani","raw_affiliation_strings":["Department of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy","G Mariani is a Staff Member at the Department of Medical Oncology, E De Benedictis is completing her fellowship in Medical Oncology and L Gianni is Director of the Division of Medical Oncology 1, A Fasolo is a Medical Oncologist, all at Istituto Nazionale Tumori, Milan, Italy.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]},{"raw_affiliation_string":"G Mariani is a Staff Member at the Department of Medical Oncology, E De Benedictis is completing her fellowship in Medical Oncology and L Gianni is Director of the Division of Medical Oncology 1, A Fasolo is a Medical Oncologist, all at Istituto Nazionale Tumori, Milan, Italy.,","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083760620","display_name":"Angelica Fasolo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Angelica Fasolo","raw_affiliation_strings":["G Mariani is a Staff Member at the Department of Medical Oncology, E De Benedictis is completing her fellowship in Medical Oncology and L Gianni is Director of the Division of Medical Oncology 1, A Fasolo is a Medical Oncologist, all at Istituto Nazionale Tumori, Milan, Italy.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"G Mariani is a Staff Member at the Department of Medical Oncology, E De Benedictis is completing her fellowship in Medical Oncology and L Gianni is Director of the Division of Medical Oncology 1, A Fasolo is a Medical Oncologist, all at Istituto Nazionale Tumori, Milan, Italy.,","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013909913","display_name":"Elena De Benedictis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elena De Benedictis","raw_affiliation_strings":["G Mariani is a Staff Member at the Department of Medical Oncology, E De Benedictis is completing her fellowship in Medical Oncology and L Gianni is Director of the Division of Medical Oncology 1, A Fasolo is a Medical Oncologist, all at Istituto Nazionale Tumori, Milan, Italy.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"G Mariani is a Staff Member at the Department of Medical Oncology, E De Benedictis is completing her fellowship in Medical Oncology and L Gianni is Director of the Division of Medical Oncology 1, A Fasolo is a Medical Oncologist, all at Istituto Nazionale Tumori, Milan, Italy.,","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058537459","display_name":"Luca Gianni","orcid":"https://orcid.org/0000-0002-2372-9625","observed_orcids":["https://orcid.org/0000-0002-2372-9625"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Luca Gianni","raw_affiliation_strings":["G Mariani is a Staff Member at the Department of Medical Oncology, E De Benedictis is completing her fellowship in Medical Oncology and L Gianni is Director of the Division of Medical Oncology 1, A Fasolo is a Medical Oncologist, all at Istituto Nazionale Tumori, Milan, Italy.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"G Mariani is a Staff Member at the Department of Medical Oncology, E De Benedictis is completing her fellowship in Medical Oncology and L Gianni is Director of the Division of Medical Oncology 1, A Fasolo is a Medical Oncologist, all at Istituto Nazionale Tumori, Milan, Italy.,","institution_ids":["https://openalex.org/I4210156707"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5058537459"],"corresponding_institution_ids":["https://openalex.org/I4210156707"],"apc_list":null,"apc_paid":null,"fwci":1.3442,"has_fulltext":false,"cited_by_count":86,"citation_normalized_percentile":{"value":0.80742459,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"6","issue":"2","first_page":"93","last_page":"104"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":1.0},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.8500000238418579},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.9179999828338623},{"id":"https://openalex.org/keywords/congestive-heart-failure","display_name":"congestive heart failure","score":0.9110000133514404},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.6399999856948853},{"id":"https://openalex.org/keywords/administration-schedule","display_name":"administration schedule","score":0.6029999852180481},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.8190000057220459},{"id":"https://openalex.org/keywords/monoclonal-antibody-therapy","display_name":"monoclonal antibody therapy","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.9848335981369019},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.8663961887359619},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8470665216445923},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7069060206413269},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5738393068313599},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.530668318271637},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5238915681838989},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5033509135246277},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4212599992752075},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4199506342411041},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4145173728466034},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.414444237947464},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.21896573901176453}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017408","descriptor_name":"Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1038/ncponc1298","doi":"https://doi.org/10.1038/ncponc1298","is_oa":false,"landing_page_url":"https://doi.org/10.1038/ncponc1298","pdf_url":null,"source":{"id":"https://openalex.org/S4210176377","display_name":"Nature Clinical Practice Oncology","issn_l":"1743-4254","issn":["1743-4254","1743-4262"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Clinical Practice Oncology","raw_type":"journal-article"},{"id":"pmid:19107109","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19107109","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature clinical practice. Oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":67,"referenced_works":["https://openalex.org/W1531524380","https://openalex.org/W1552329178","https://openalex.org/W1578891068","https://openalex.org/W1606090394","https://openalex.org/W1964641698","https://openalex.org/W1968863785","https://openalex.org/W1982210988","https://openalex.org/W1992234802","https://openalex.org/W1995242599","https://openalex.org/W2000092807","https://openalex.org/W2001447115","https://openalex.org/W2009218955","https://openalex.org/W2019895529","https://openalex.org/W2020849074","https://openalex.org/W2025968984","https://openalex.org/W2030754505","https://openalex.org/W2030796899","https://openalex.org/W2035484878","https://openalex.org/W2037195973","https://openalex.org/W2044230523","https://openalex.org/W2045324973","https://openalex.org/W2045735044","https://openalex.org/W2048686497","https://openalex.org/W2050674912","https://openalex.org/W2054949014","https://openalex.org/W2059170159","https://openalex.org/W2059411043","https://openalex.org/W2063679320","https://openalex.org/W2070959431","https://openalex.org/W2073871328","https://openalex.org/W2093332042","https://openalex.org/W2094627540","https://openalex.org/W2100375606","https://openalex.org/W2103019840","https://openalex.org/W2104337757","https://openalex.org/W2115759102","https://openalex.org/W2117115931","https://openalex.org/W2122080125","https://openalex.org/W2122472092","https://openalex.org/W2126620646","https://openalex.org/W2130922851","https://openalex.org/W2133573244","https://openalex.org/W2138498230","https://openalex.org/W2140074016","https://openalex.org/W2140618548","https://openalex.org/W2141393790","https://openalex.org/W2141469083","https://openalex.org/W2143673928","https://openalex.org/W2144124503","https://openalex.org/W2146384083","https://openalex.org/W2146406055","https://openalex.org/W2148860061","https://openalex.org/W2149908785","https://openalex.org/W2159459001","https://openalex.org/W2160329331","https://openalex.org/W2160540392","https://openalex.org/W2165824128","https://openalex.org/W2166666753","https://openalex.org/W2166827435","https://openalex.org/W2171583003","https://openalex.org/W2172265576","https://openalex.org/W2313649997","https://openalex.org/W2318605753","https://openalex.org/W2467250903","https://openalex.org/W2596220970","https://openalex.org/W2596875443","https://openalex.org/W2781566818"],"related_works":["https://openalex.org/W1996896645","https://openalex.org/W2957213237","https://openalex.org/W2043306447","https://openalex.org/W2367874297","https://openalex.org/W2001633715","https://openalex.org/W2944662988","https://openalex.org/W2000138179","https://openalex.org/W2420535504","https://openalex.org/W2589437138","https://openalex.org/W1976099551"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2006508449","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
